Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2a Trial to Evaluate the Efficacy and the Safety of BLS_ILB_E710c for the Fertile Women With Cervical Intraepithelial Neoplasia(CIN3)

NCT02195089 is registered in ClinicalTrials.gov with BioLeaders Corporation as lead sponsor.

NCT NCT02195089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02195089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2a Trial to Evaluate the Efficacy and the Safety of BLS_ILB_E710c for the Fertile Women With Cervical Intraepithelial Neoplasia(CIN3)
Lead sponsor
BioLeaders Corporation
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2014
Completion date
April 30, 2016
Enrollment
19 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cervical intraepithelial neoplasia